Wegovy FlexTouch Pre-filled Pen (Semaglutide) | Weight Loss Injection | GLP-1 Therapy
Wegovy FlexTouch is the initial low-dose step of semaglutide therapy used for weight management and obesity treatment. It supports gradual weight loss by reducing appetite and improving satiety, by controling calorie intake, slow digestion, and support significant long-term weight loss under medical supervision..
Product Overview
Wegovy FlexTouch Pre-filled Pen is a once-weekly injectable used for chronic weight management in adults who are overweight or obese. It is administered subcutaneously (under the skin) using a pre-filled pen. It contains Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that acts on the same targets in the body as the natural hormone GLP-1. By mimicking these hormonal signals, Wegovy provides a dual-action approach: it regulates the brain’s hunger centers to reduce appetite and slows the digestive process to prolong feelings of fullness. This specialized therapy is designed to be used alongside a reduced-calorie diet and increased physical activity to help individuals achieve and maintain significant weight loss.
Product Composition
The efficacy of this treatment is driven by its highly stabilized active ingredient:
- Semaglutide: A long-acting GLP-1 analogue that communicates with the brain to increase satiety and decrease cravings, while also improving metabolic glucose response.
Product Specification
| Feature | Details |
| Therapeutic Class | GLP-1 Receptor Agonist / Weight Management |
| Active Ingredient | Semaglutide |
| Administration | Subcutaneous Injection (SC) |
| Frequency | Once Weekly |
| Device Type | FlexTouch Pre-filled, Multi-dose Pen |
Mechanism of Action
Wegovy FlexTouch works by integrating with the body's natural metabolic and neurological pathways:
- Appetite Regulation: The medication targets specific areas in the hypothalamus that control hunger. By activating these receptors, it decreases the "hunger drive" and reduces the preoccupation with food.
- Enhanced Satiety: It increases the feeling of fullness and satisfaction after eating, making it easier for individuals to adhere to smaller portion sizes.
- Gastric Emptying Modulation: It slows the rate at which the stomach empties its contents into the small intestine. This delayed digestion helps prevent sharp spikes in blood sugar and keeps the patient feeling full for a longer duration.
- Glucagon Suppression: It helps manage blood sugar levels by reducing the liver's production of excess glucose, contributing to overall metabolic stability.
Key Benefits
- Clinically Proven Weight Loss: Demonstrates significant and sustained reduction in body weight compared to diet and exercise alone in clinical trials.
- Once-Weekly Convenience: The long half-life of the medication allows for a single weekly dose, eliminating the need for daily pills or injections.
- Cardiovascular Risk Reduction: In addition to weight loss, it has been shown to reduce the risk of major adverse cardiovascular events in adults with established heart disease and obesity or overweight.
- Precision Dosing: The FlexTouch pen is engineered for accuracy, allowing users to dial the exact dose prescribed with a simple click mechanism.
- Improved Metabolic Health: Beyond weight loss, users often see improvements in waist circumference, blood pressure, and lipid profiles.
Precautions
Wegovy FlexTouch Pre-filled Pen (Semaglutide) should be used carefully under medical supervision for safe and effective weight management.
Medical Conditions to Inform Your Doctor
| Condition | Why It Matters |
|---|---|
| Pancreatitis history | May increase risk of pancreatic inflammation |
| Thyroid cancer or MEN2 syndrome | Possible increased risk with GLP-1 therapy |
| Severe gastrointestinal disease | May worsen nausea, vomiting, and delayed gastric emptying |
| Kidney disease | Dehydration from side effects may affect kidney function |
| Gallbladder disease | May increase risk of gallstones |
| Diabetic retinopathy | Rapid glucose changes may temporarily worsen eye condition |
Dosing and Use Precautions
- Use exactly as prescribed (0.25 mg to 2.4 mg titration schedule)
- Administer once weekly on the same day each week
- Do not increase or skip doses without medical advice
- Rotate injection sites (abdomen, thigh, or upper arm)
Gastrointestinal Effects
- Nausea, vomiting, or diarrhea are common during dose escalation
- Eat small, low-fat meals to reduce discomfort
- Maintain adequate hydration to avoid dehydration
Hypoglycemia Risk
- Increased risk when used with insulin or sulfonylureas
- Monitor blood sugar regularly if combined with diabetes medicines
Pregnancy and Breastfeeding
- Not recommended during pregnancy
- Should be avoided during breastfeeding unless prescribed
General Advice
- Do not stop treatment suddenly without medical guidance
- Store as per instructions (usually refrigerated)
- Inform your doctor about all medications you are taking
- Regular monitoring of weight and metabolic health is recommended
Usage
The effective use of the Wegovy FlexTouch Pre-filled Pen depends on a consistent weekly schedule and a gradual dose escalation to ensure the best results while allowing the body to adapt.
Dosage & Administration
Treatment follows a strictly defined titration schedule, typically starting at a low dose (0.25 mg) and increasing every four weeks until the maintenance dose is reached. This gradual approach is essential for minimizing gastrointestinal side effects.
| Aspect | Recommendation |
| Standard Frequency | Once weekly, on the same day each week |
| Administration Route | Subcutaneous (SC) injection only |
| Injection Sites | Abdomen, thigh, or upper arm |
| Dose Timing | Can be administered at any time of day, with or without meals |
Administration Protocol
Pen Preparation: Before use, ensure the liquid in the pen window is clear and colorless. Always use a new, sterile needle for every weekly injection.
Setting the Dose: Turn the dose selector on the FlexTouch pen until the counter shows the dose prescribed by your healthcare provider.
The Injection: Insert the needle into the skin. Press and hold the dose button until the counter returns to zero. Maintain pressure and count slowly to 6 to ensure the full dose has been delivered before withdrawing the needle.
Site Rotation: Rotate the injection site each week. You may use the same body area (e.g., the abdomen), but ensure the specific injection point is different from the previous week.
Storage: Unused pens should be stored in the refrigerator between 2°C and 8°C. After the first use, the pen can be stored for up to 56 days either in the refrigerator or at room temperature (below 30°C).
Uses
Wegovy is a targeted hormonal therapy used for long-term metabolic regulation and weight management in specific patient populations.
Chronic Weight Management: Indicated for adults with a Body Mass Index (BMI) of 30 kg/m² or greater (obesity), or 27 kg/m² or greater (overweight) in the presence of at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia.
Pediatric Weight Management: Used for chronic weight management in pediatric patients aged 12 years and older with an initial BMI at the 95th percentile or greater standardized for age and sex.
Cardiovascular Risk Mitigation: Used to reduce the risk of major adverse cardiovascular events (such as cardiovascular death, non-fatal heart attack, or non-fatal stroke) in adults with established cardiovascular disease and either obesity or overweight.
Appetite and Cravings Control: Helps individuals maintain a reduced-calorie diet by targeting brain receptors to increase satiety and decrease the frequency and intensity of hunger signals.
Metabolic Health Support: Assists in improving various health markers, including waist circumference and blood sugar stability, as part of a comprehensive weight-loss program.
Side Effects
Wegovy FlexTouch Pre-filled Pen (Semaglutide) may cause side effects, especially during dose escalation. Most effects are mild to moderate and improve as the body adjusts to treatment.
Common Side Effects
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Abdominal pain or discomfort
- Loss of appetite
- Indigestion
Less Common Side Effects
- Dizziness
- Fatigue
- Bloating
- Acid reflux
- Injection site reactions (redness, swelling, or itching)
Serious Side Effects
| Serious Condition | Symptoms |
|---|---|
| Pancreatitis | Severe abdominal pain, vomiting, pain radiating to back |
| Severe hypoglycemia | Sweating, confusion, shakiness, fainting |
| Gallbladder disease | Upper abdominal pain, fever, yellowing of skin or eyes |
| Severe dehydration | Very low urine output, dizziness, extreme thirst |
| Allergic reaction | Rash, swelling of face/lips, breathing difficulty |
Important Advice
- Side effects are more common during the first few weeks or dose increases
- Eat smaller, low-fat meals to reduce nausea
- Stay well hydrated to prevent dehydration
- Report severe or persistent symptoms to a doctor immediately
FAQs
Q: What is Wegovy FlexTouch Pre-filled Pen (Semaglutide) used for?
A: It is used for chronic weight management and obesity treatment. It helps reduce appetite, control food intake, and support long-term weight loss.
Q: How does Wegovy work?
A: Wegovy works as a GLP-1 receptor agonist that reduces hunger, slows gastric emptying, increases fullness, and helps regulate body weight.
Q: How is Wegovy FlexTouch Pen used?
A: It is given as a once-weekly subcutaneous injection in the abdomen, thigh, or upper arm as directed by a doctor.
Q: What are the available strengths of Wegovy?
A: It is available in 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg strengths depending on the treatment stage.
Q: What are the common side effects of Wegovy?
A: Common side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, and reduced appetite.
Q: How long does it take to see weight loss results?
A: Noticeable weight loss may take a few weeks to months depending on diet, lifestyle, and consistent use.
Q: Can Wegovy cause low blood sugar?
A: Yes, especially when used with insulin or sulfonylureas, so blood sugar monitoring is important.
Q: Who should avoid Wegovy?
A: It should be avoided in patients with a history of medullary thyroid cancer, MEN2 syndrome, or severe gastrointestinal disorders unless prescribed by a doctor.
Interactions
Wegovy FlexTouch Pre-filled Pen (Semaglutide) may interact with certain medicines, affecting blood sugar control, drug absorption, and overall treatment response.
Antidiabetic Medicines
| Medicine Class | Interaction Effect |
|---|---|
| Insulin | Increased risk of hypoglycemia (low blood sugar) |
| Sulfonylureas (e.g., glimepiride, gliclazide) | Higher risk of low blood sugar, may require dose adjustment |
| Other GLP-1 receptor agonists | Not recommended due to additive effects and increased side effects |
Other Medicines
- Oral medicines may have delayed absorption due to slowed gastric emptying
- Warfarin may require closer INR monitoring due to changes in diet and intake
- Thyroid medicines (e.g., levothyroxine) may need timing adjustments for proper absorption
- Diuretics may increase risk of dehydration, especially with nausea or vomiting
- Oral contraceptives may have reduced effectiveness in some patients during initiation
General Advice
- Inform your doctor about all prescription, OTC, and herbal medicines
- Monitor blood sugar regularly, especially when combined with insulin or sulfonylureas
- Maintain proper hydration to reduce risk of kidney-related issues
- Follow prescribed weekly dosing schedule strictly (0.25 mg to 2.4 mg)
- Do not start, stop, or change any medicine without medical supervision
| Manufacturer | : | Novo Nordisk India Pvt Ltd |
| Trade Name | : | Ozempic |
| Generic Search | : | Semaglutide |
| Strength | : | 0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg |
Latest Products
